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Chapter 1
Introduction
Often in a clinical setting, it is of interest to know a patient’s risk for developing a certain
disease or other adverse outcomes to support clinical decision making. This can be accomplished
through the use of a risk prediction model or risk score. Some examples of risk scores include the
Framingham risk score (Hippisley-Cox et al., 2008), which estimates the 10-year risk of developing
cardiovascular disease and is useful in outpatient or self-care settings and the Sepsis-related Organ
Failure Assessment (SOFA) score (Vincent et al., 1996), which describes organ dysfunction/failure
and is useful in an acute care setting. Being able to accurately predict a patient’s risk for an adverse
outcome can be beneficial at a population level by helping to control chronic diseases and at an
individual level by helping the healthcare workers to deliver an effective intervention in a timely
manner.
Risk prediction models are usually developed using research-based large cohort studies or clin-
ical trials, which are often not representative of the local population of interest (Goldstein et al.,
2016). Model validation using the local patient population has to be conducted before existing risk
prediction models can be used in local clinical practice. Rapid deployment of electronic health
record (EHR) systems provides unique opportunities and resources for such validation studies
(Kolek et al., 2016; Riley et al., 2016).
Conducting research studies using EHR data presents several challenges as well. There could
be systematically missing predictor values, meaning that a predictor is not measured for any indi-
viduals in one or more clusters. In this case, a method such as multiple imputation would have to
be performed. Also of concern when using EHR data is the quality of the data. Potential concerns
are issues such as missing data, non-standardized definitions of outcomes, and incomplete follow-
up times and event dates (Riley et al., 2016). It is also possible that incorrect values for variables
of interest could be present in EHR data. For example, in a validation study for the CHARGE-AF
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risk prediction (Alonso et al., 2013), EHR data from a cohort of 33,494 patients is used (Kolek
et al., 2016). For risk factor data extraction, treatment of hypertension and current smoking status
were determined using previously validated algorithms with a sensitivity value of 88% for treat-
ment of hypertension and positive predictive values of 93% for both. In other words, 88 out of
100 patients truly receiving treatment of hypertension were correctly identified and 93 out of 100
identified current smokers are true current smokers. Therefore, data errors could potentially have
been present in those variables. To deal with these concerns, it is often necessary for physicians
to perform chart reviews, which can be very time consuming and sometimes not feasible for large
EHR datasets such as the CHARGE-AF validation study.
Another motivating study aims to evaluate the established Sepsis-related Organ Failure As-
sessment (SOFA) score in predicting 30-day mortality since ICU admission using EHR data. A
SOFA score consists of six components corresponding to the following six organ systems: respi-
ratory, cardiovascular, neurologic, hematological, renal, and hepatic (Vincent et al., 1996). Each
component is assigned an integer value between 0 and 4. Sepsis is a syndrome of physiologic,
pathologic, and bio-chemical abnormalities induced by infection and is the primary cause of death
from infection, especially if not recognized and treated promptly. A consensus definition for sepsis
has been developed and revised in the past two decades for early diagnosis of sepsis. Recently, the
third international consensus definition for sepsis was released (Singer et al., 2016), where change
in total SOFA score greater than two points was included as a major component of sepsis diagnosis
criteria. Due to rapid deterioration of sepsis patients, it is critical that the SOFA score be calcu-
lated as quickly as possible for ICU patients, and thus development of computerized algorithms to
automatically calculate the SOFA score by using natural language processing to extract data from
the EHR is warranted. However, the information needed to calculate the SOFA score may not be
accurately recorded in the EHR data, and it may require a check of the nurses’ notes or other writ-
ten sources of information, i.e. chart review. In this motivating study, it is of interest to compare an
electronically derived SOFA score (eSOFA) with the gold standard manually derived SOFA score
(mSOFA) based on chart review in predicting 30-day mortality since ICU admission.
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The purpose of this paper is two-fold: (1) to evaluate the impact of data quality problems on
risk prediction; (2) and to compare two chart review sampling strategies, case-cohort sampling
and random sampling, to correct data errors and assess the impact of these corrections on risk
prediction. The rest of the paper is organized as follows. Chapter 2 introduces chart reviews
and proposes two sampling strategies for choosing the patients for which the chart reviews will
be performed. Chapter 3 details simulation studies that were performed to assess the impact of
data quality issues on the risk factor effects and risk prediction model performance under a Cox
proportional hazards model. Various scenarios combining different risk factor distributions, event
rates, and error rates are considered. The simulation also includes correction of the data errors
using the chart review strategies introduced in Chapter 2 to examine how this impacts the models.
In Chapter 4, the strategies introduced in Chapter 2 are applied to compare eSOFA and mSOFA
in predicting 30-day mortality for ICU patients using EHR data from the Isotonic Solutions and
Major Adverse Renal Events Trial (SMART) (Semler et al., 2018). Finally, the findings and future
work are discussed in Chapter 5.
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Chapter 2
Chart Review Strategies
Chart reviews are particularly important for retrospective studies. These types of studies use
pre-recorded, patient focused data to address research questions that are not able to be answered
using a prospective study, such as the effects of a harmful or beneficial exposure to which subjects
cannot be randomized or the occurrence of a rare event after an exposure to which subjects cannot
be randomized (Worster and Haines, 2004). With smaller datasets, it’s relatively easy to review
all the records. However, with the growing size of EHR data, this is more of a challenge, so a
reasonable sample size of charts to be reviewed must be determined. Typically, the records to be
reviewed are selected by a type of convenience sampling where all records within a given time
frame are chosen or by a random sampling of records from the population of interest (Worster and
Haines, 2004).
Chart reviews are also used for validating phenotyping algorithms where patients with certain
traits, diseases, or responses to medication are identified through combined resources extracted
from EHR data using various computation approaches such as natural language processing, as was
discussed by Kirby et al. (2016) using the Electronic Medical Records and Genomics (eMERGE)
network. Case-control sampling strategies are usually used to develop phenotyping algorithms,
where the phenotyping algorithm performance is mainly evaluated using sensitivity and positive
predictive values.
For studies to develop or evaluate risk prediction models using EHR data, a random sampled
dataset might not include a sufficient number of events to provide reliable results, which is par-
ticularly concerning for rare diseases. Alternatively, we could consider a case-cohort sampling
strategy for choosing the patients whose charts will be reviewed. The concept of the case-cohort
sampling strategy comes from the case-cohort design proposed by Prentice (1986). In the case-
cohort chart review sampling strategy, all cases and a random sample of non-cases will be chart
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reviewed. Note that all the studies discussed so far only consider using the sampled chart reviewed
records to draw conclusions while assuming results from chart reviewed data are applicable to the
underlying population of interest.
The goal of this paper is to use the entire study population corroborated with chart reviewed
records. The impact of chart review sampling strategies in the context of risk prediction models
will be investigated. First, the risk prediction model will be fit without correcting any data errors.
Next, chart reviews will be performed to correct any data errors in the sample of records that are
reviewed. To choose the patients whose records are reviewed, a random sampling strategy will
be used as well as the alternative strategy using case-cohort sampling. Then, the risk prediction
model will be refit and the impact of the data correction will be assessed for each of the chart
review sampling strategies.
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Chapter 3
Simulation
3.1 Simulation Settings
In this chapter, extensive simulations are conducted. For each simulation, N = 5,000 subjects
are generated from a Cox proportional hazards model
λ (t|Z) = λ0(t)exp(βTZ),
where β = (0.3,0.5,0.3,0.5,0.3,0.5) is a vector of coefficients and Z= (Z1,Z2,Z3,Z4,Z5,Z6) is a
vector of covariates representative of the six types of risk factors that might be found in EHR data:
Z1 was continuous (e.g. age), Z2 was binary (e.g. gender), Z3 was continuous and dependent on
Z1 and Z2 (e.g. systolic blood pressure), Z4 was binary and dependent on Z1 and Z2 (e.g. medical
history of cardiovascular disease), Z5 was continuous and independent of all other covariates (e.g.
BMI), and Z6 was binary and independent of all other covariates (e.g. smoking status). The
following distribution was used to generate Z:

X1
X2
X3
X4
X5
X6

∼ N


0
0
0
0
0
0

,

1 0 0.2 0.2 0 0
0 1 0.2 0.2 0 0
0.2 0.2 1 0 0 0
0.2 0.2 0 1 0 0
0 0 0 0 1 0
0 0 0 0 0 1


.
For the continuous covariates, Z1 = X1, Z3 = X3, and Z5 = X5. To generate the following distributions
for binary covariates: Z2 ∼ Bin(0.5), Z4 ∼ Bin(0.3), and Z6 ∼ Bin(0.3), let Z2 = I(X2 > 0), Z4 =
I(X4 > Φ−1(0.7)), and Z6 = I(X6 > Φ−1(0.7)), where I(·) is an indicator function and Φ is the
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cumulative distribution function for the standard Normal distribution. Two scenarios for λ0(t) and
censoring distributions are considered: (1) λ0(t) = 0.005 and C ∼ exp(0.21); and (2) λ0(t) = 0.05
and C ∼ exp(0.4), which results in event rate of approximately 5% and 20% respectively. The
following was used to simulate the event times, T:
S(T ) = e−Λ0(T )e
βZ
where S(T ) =U ∼U(0,1).
=⇒ Λ0(T ) = −log(U)e−βZ
T = − T
Λ0(T )
log(U)e−βZ
3.2 Error Scenarios
Next, the observed covariates Z∗=(Z1,Z2,Z∗3 ,Z
∗
4 ,Z
∗
5 ,Z
∗
6) were created by adding errors to each
of the four underlying true covariates Z3, Z4, Z5, and Z6 one at a time and with four different error
rates, ER= 5%,10%,20%, and 30%, resulting in a total of 16 error scenarios. Specifically, for the
first four scenarios, Z∗3 = Z3 + ε with ε ∼ N(0,0.25) for ER ∗N randomly selected observations
(e.g. 250 observations for a 5% error rate), and the rest of the observations were the same as Z. For
the next four scenarios, Z∗5 = Z5+ε with ε ∼N(0,0.25) for ER∗N randomly selected observations
and the rest of the observations were the same as Z. For the four scenarios involving Z4, among all
observations with Z4 = 1, a proportion of ER observations were randomly selected such that Z∗4 = 0
and the rest of the observations were the same as Z. Using an error rate of 20%, approximately
20%∗P(Z4 = 1) = 6% of observations had error introduced. Similar approaches were used for the
last four scenarios involving Z6.
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3.3 Chart Review Sampling Scenarios
A sample size of 500 was chosen for the number of chart reviews to perform. The first sampling
strategy used to choose which subjects had chart reviews performed was random sampling. In this
strategy, 500 subjects were randomly chosen to be reviewed regardless of whether or not they
experienced an event. Next, case-cohort sampling was used to choose which subjects had chart
reviews. For the 5% event rate, all cases were reviewed and 500−Nc non-cases were reviewed,
where Nc was the number of cases. For the 20% event rate, 500 cases were reviewed. The following
was performed for each of the four scenarios. For the 500 subjects chosen to have their charts
reviewed, the true covariate values (Z) were used instead of the observed covariate values (Z∗). The
same 16 Cox proportional hazards models discussed in section 3.2 were refit using the corrected
data, and the summary measures discussed below were calculated for these models.
3.4 Summary Measures
Within each simulation, four models with different covariates were fitted for each of the 16
error scenarios. The first model used Z representing the true model. The second model used Z∗
representing the error model. The third model used Z∗ compensated by a case-cohort sampling
chart review strategy. The fourth model used Z∗ compensated by a random sampling chart review
strategy. A total of 500 simulations were run, and the results for β estimators were summarized us-
ing percent bias, mean square error, and coverage probability. The C-index was used as a measure
of discrimination of the models. Let βi be the truth and let βˆi j for i = 1,2,...,6 denote an estimate of
βi from the jth simulation. Let
¯ˆβi =
∑500j=1 βˆi j
500 denote the mean of βˆi from all 500 simulations.
The bias was calculated using the formula Bias( ¯ˆβi,βi) =
¯ˆβi−βi, and the percent bias was found
using the formula Bias(
¯ˆβi,βi)
βi
∗ 100. A positive percent bias indicates overestimation of the true βi,
and a negative percent bias indicates underestimation of the true βi.
The mean square error (MSE) is a measure that takes into account both variance and bias. It
was found using the formula MSE( ¯ˆβi,βi) = 1500 ∑
500
j=1(βˆi j−βi)2 = Var( ¯ˆβi)+(Bias( ¯ˆβi,βi))2.
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The coverage probability for βˆi gives the proportion of the 500 βˆi j’s that fall within their asso-
ciated 95% confidence intervals. The confidence interval for the jth simulation is found using the
formula βˆi j±1.96∗SE(βˆi j).
The C-index, or concordance probability, is a measure of discrimination for the Cox propor-
tional hazards model. This measure is a generalization of the area under a receiver operating
characteristic (ROC) curve. To calculate the C-index, the survival times of pairs of subjects are
ordered. If both subjects are censored or if one subject has experienced an event and the follow-up
time of the other subject is less than the event time of the first, then this pair of subjects’ survival
times cannot be ordered. The C-index is the proportion of all possible pairs of subjects such that
the subject with the higher predicted survival is the one who survived longer. A C-index value
of 0.5 indicates random predictions, and a value of 1 indicates that the model results in perfect
predictions (Harrell, 2015).
3.5 Results
3.5.1 Continuous Covariates
The Cox proportional hazards model results from the simulations using the observed continu-
ous covariates Z∗3 and Z
∗
5 and true continuous covariates Z3 and Z5 at all four error rate scenarios
from both the 5% and 20% event rate scenarios can be found in Table 3.1. Using the true covariate
Z3, the percent bias for βˆ3 was -1.39 at a 5% event rate and -1.38 at a 20% event rate. Using Z∗3 , the
magnitude of the percent bias increased at both event rates, and it was more pronounced at higher
error rates as expected. At the 5% event rate, the percent bias ranged from -2.75 at a 5% error rate
to -8.88 at a 30% error rate, and at the 20% event rate, it ranged from -2.75 to -9.25. The C-index
using the true covariates was 0.7 at a 5% event rate and 0.69 at a 20% event rate. The percent bias
for the C-index when using Z∗3 was very small at all error rates, ranging from -0.03 to -0.14 at a
5% event rate and -0.03 to -0.16 at a 20% event rate.
The percent biases for βˆ1 and βˆ2 were also affected by the errors added to Z3 because Z3 was
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generated to be dependent on Z1 and Z2. For β1, the percent bias was higher when using Z∗3 , and it
increased with increasing error rates at both event rates. The percent bias for βˆ1 ranged from 1.58
at a 5% error rate to 2.81 at a 30% error rate compared to 1.32 with no errors at a 5% event rate.
At a 20% event rate, this percent bias ranged from 1.31 to 2.48 compared to 1.06 without errors.
The percent bias for βˆ2 behaved similarly to what was described for βˆ1, with a higher percent bias
than βˆ2 without errors and increasing percent bias as the error rate increased.
For the true independent covariate (Z5), the percent bias with no errors at a 5% event rate was
1.05, and at a 20% event rate, it was -0.12. Similar patterns to what were described above for
the true dependent covariate Z3 were found here. When errors were introduced, the percent bias
became more pronounced as the error rate increased. The magnitude of the percent bias for the
observed independent covariate (Z∗5) is slightly smaller than it is for the corresponding observed
dependent covariate (Z∗3) at all event rates and error rates. Also, the percent bias of the C-index
when using Z∗5 is comparable to what was found for the scenarios using Z
∗
3 .
The results using the observed continuous covariates (Z∗3 and Z
∗
5) after performing chart reviews
using random sampling can be found in Table 3.2. Similarly, the results after performing chart
reviews using case-cohort sampling are summarized in Table 3.3. The patterns for both chart
review sampling strategies are similar to those that were found in Table 3.1. The percent bias for
the C-index is very similar to what was found without performing chart reviews. However, the
magnitude of the percent bias for β3 and β5 is slightly smaller after performing chart reviews.
See Tables 3.2 and 3.3 for details. Also, there is about a 10% reduction in the percent bias after
correcting errors using chart review. For example, the percent bias for βˆ5 is reduced by an average
of about 8.93% over all four error rates when using a 20% event rate with random sampling chart
review, and it’s reduced by an average of about 12.97% over all four error rates when using a 20%
event rate with case-cohort sampling chart review.
Figure 3.1 displays the percent bias of the effect estimates for both the independent (Z5) and
dependent (Z3) continuous covariates at each of the four error rates and at both the 5% and 20%
event rates. The lines show the impact of increasing error rates on the percent bias, with a different
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color for each of the chart review strategies. Overall, it appears that the case-cohort strategy tends
to perform better in terms of percent bias than the random sampling strategy, and both chart review
strategies perform slightly better than no chart review. Also, the difference is more distinct at
higher error rates.
Figure 3.1: Percent Bias for Continuous Covariates
(a) Z3, 5% event rate (b) Z5, 5% event rate
(c) Z3, 20% event rate (d) Z5, 20% event rate
3.5.2 Binary Covariates
Table 3.4 displays the Cox proportional hazard model results from the simulations using the
observed binary covariates Z∗4 and Z
∗
6 and true binary covariates Z4 and Z6 at all four error rates
from both the 5% and 20% event rate scenarios. For the dependent covariate (Z4) at a 5% event
rate, the percent bias for the effect estimate (βˆ4) was -0.11 when using the true covariate Z4. When
using the observed covariate Z∗4 , the magnitude of the percent bias increased with increasing error
rates. Also, the percent bias became more pronounced as the error rate increased. At a 5% error
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rate, the percent bias for βˆ4 was -3.50, and at a 30% error rate, the percent bias was -17.04. A
similar pattern was found for the dependent covariate at a 20% event rate. The percent bias in this
scenario was -0.01 with no errors, -2.87 at a 5% error rate, and -15.66 at a 20% error rate. At a 5%
event rate, the percent bias of the C-index when using Z∗4 ranged from -0.09 at a 5% error rate to
-0.54 at a 30% error rate, and at a 20% event rate, the it ranged from -0.11 to -0.58.
The percent biases for βˆ1 and βˆ2 were also affected by the errors added to Z4 because Z4 was
dependent on Z1 and Z2. The percent bias for βˆ1 when using the true Z4 was 1.32 at a 5% event rate
and 1.06 at a 20% event rate. For βˆ2, the percent bias was -1.22 at a 5% event rate and 0.53 at a
20% event rate when using Z4 with no errors. The percent bias was higher for both effect estimates
when using Z∗4 , and it increased with increasing error rates at both event rates. See Table 3.4 for
details.
The percent bias for the effect estimate for the independent covariate (Z6) when using Z6 with
no errors was 1.68 at a 5% event rate and 1.05 at a 20% event rate. A similar pattern was found
for the observed independent covariate Z∗6 as was described above for the observed dependent
covariate Z∗4 . The magnitude of the percent bias increased with increasing error rates, and the
percent bias became more pronounced as the error rate increased. Also, the percent bias for the
C-index when using Z∗6 was very similar to what was found for the C-index when using Z
∗
4 . See
table 3.4 for details.
The results from fitting the models after performing chart reviews with random sampling are
shown in Table 3.5. The behavior resembles what was found from the modesl without performing
chart reviews. The percent bias is negative in all scenarios and the magnitude increases as the
event rate increases. Also, the percent bias of the dependent covariate is more pronounced than the
percent bias of the independent covariate for both event rates and all error rates. The percent biases
for the C-index were also very similar at all error rates and both event rates to what was found
without performing chart reviews. See Table 3.5 for details. Also, there is about a 10% reduction
in the percent bias after correcting errors using random sampling chart review. For example, the
percent bias for βˆ6 is reduced by an average of about 11.64% over all four error rates when using
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a 20% event rate with random sampling chart review.
In Table 3.6, the results from fitting the models with the observed binary covariates (Z∗4 and
Z∗6) after performing chart reviews using case-cohort sampling are shown. The pattern is the same
as was described for the binary covariates without chart reviews performed; the magnitude of the
percent bias increased as the error rate increased. However, the percent biases after performing
chart reviews using case-cohort sampling are all positive and a much greater magnitude than those
without using chart review. At a 30% error rate and a 5% event rate, the effect estimate for the
dependent covariate (βˆ4) after performing case-cohort sampling chart review had a percent bias
of 84.49 compared to -17.04 without chart review. During the chart review process, incorrect 0’s
were changed to correct 1’s for all cases and a portion of non-cases at the 5% event rate and for
500 cases and no non-cases at the 20% event rate. This resulted in different Z4 and Z6 distributions
for the cases and the non-cases, which explains the large positive percent bias seen here. Also, the
percent bias for the C-index is positive at all error rates, and it is more pronounced than the percent
bias for the C-index without performing chart reviews.
Figure 3.2 displays the percent bias for the effect estimates of the observed dependent (Z∗4)
and independent (Z∗6) binary covariates at both the 5% event rate and the 20% event rate. As was
discussed above, performing chart reviews with case-cohort sampling results in a large positive
percent bias, so this scenario was not included in this plot. Random sampling chart review has
slightly less pronounced bias than no chart review with a larger difference at higher error rates.
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Figure 3.2: Percent Bias for Binary Covariates
(a) Z4, 5% event rate (b) Z6, 5% event rate
(c) Z4, 20% event rate (d) Z6, 20% event rate
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Table 3.1: Simulation Results for Continuous Covariates
5% Error Rate 10% Error Rate 20% Error Rate 30% Error Rate No Error
Truth % Bias MSE0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP
β1 0.3 1.58 0.41 0.95 1.83 0.41 0.95 2.32 0.41 0.96 2.81 0.41 0.96 1.32 0.41 0.95
β2 0.5 -0.96 1.98 0.94 -0.70 1.97 0.94 -0.24 1.96 0.94 0.24 1.96 0.94 -1.22 1.99 0.94
β3 0.3 -2.75 0.42 0.95 -3.98 0.43 0.94 -6.41 0.45 0.95 -8.88 0.45 0.95 -1.39 0.43 0.95
β4 0.5 -0.19 1.82 0.95 -0.25 1.82 0.95 -0.44 1.82 0.95 -0.63 1.83 0.95 -0.11 1.83 0.95
β5 0.3 1.04 0.38 0.96 1.05 0.38 0.96 1.01 0.38 0.96 0.98 0.39 0.96 1.05 0.38 0.96
β6 0.5 1.68 1.79 0.94 1.68 1.80 0.94 1.65 1.80 0.94 1.62 1.79 0.94 1.68 1.80 0.94
5% Event Rate C-Index 0.7 -0.03 -0.05 -0.09 -0.14
β1 0.3 1.34 0.41 0.95 1.31 0.41 0.95 1.30 0.41 0.96 1.26 0.41 0.95 1.32 0.41 0.95
β2 0.5 -1.23 1.99 0.94 -1.27 1.98 0.93 -1.25 1.99 0.93 -1.30 1.99 0.94 -1.22 1.99 0.94
β3 0.3 -1.4 0.43 0.95 -1.42 0.43 0.95 -1.41 0.43 0.95 -1.39 0.43 0.95 -1.39 0.43 0.95
β4 0.5 -0.13 1.83 0.95 -0.14 1.82 0.95 -0.15 1.83 0.95 -0.13 1.83 0.95 -0.11 1.83 0.95
β5 0.3 -0.05 0.38 0.96 -1.32 0.37 0.97 -3.90 0.38 0.96 -6.38 0.40 0.94 1.05 0.38 0.96
β6 0.5 1.68 1.80 0.93 1.67 1.80 0.93 1.69 1.80 0.93 1.69 1.80 0.94 1.68 1.80 0.94
C-Index 0.7 -0.02 -0.04 -0.10 -0.16
β1 0.3 1.31 0.12 0.95 1.58 0.12 0.95 2.05 0.12 0.95 2.48 0.12 0.95 1.06 0.12 0.95
β2 0.5 0.77 0.46 0.94 1.03 0.46 0.94 1.48 0.46 0.94 1.92 0.47 0.94 0.53 0.46 0.94
β3 0.3 -2.75 0.12 0.95 -4.15 0.12 0.93 -6.82 0.15 0.90 -9.25 0.18 0.85 -1.38 0.11 0.95
β4 0.5 -0.11 0.45 0.95 -0.22 0.45 0.95 -0.45 0.45 0.94 -0.65 0.45 0.95 -0.01 0.45 0.95
β5 0.3 -0.14 0.10 0.95 -0.16 0.10 0.95 -0.24 0.10 0.95 -0.28 0.10 0.95 -0.12 0.10 0.96
β6 0.5 1.03 0.44 0.95 0.99 0.44 0.95 0.94 0.44 0.95 0.89 0.44 0.95 1.05 0.44 0.95
20% Event Rate C-Index 0.69 -0.03 -0.06 -0.11 -0.16
β1 0.3 1.05 0.12 0.95 1.02 0.12 0.95 0.96 0.12 0.95 0.89 0.12 0.95 1.06 0.12 0.95
β2 0.5 0.5 0.46 0.94 0.44 0.46 0.94 0.45 0.46 0.94 0.35 0.45 0.94 0.53 0.46 0.94
β3 0.3 -1.41 0.11 0.95 -1.43 0.11 0.95 -1.46 0.11 0.95 -1.48 0.11 0.95 -1.38 0.11 0.95
β4 0.5 -0.04 0.45 0.95 -0.07 0.45 0.94 -0.13 0.45 0.95 -0.10 0.45 0.95 -0.01 0.45 0.95
β5 0.3 -1.35 0.10 0.96 -2.64 0.10 0.95 -5.08 0.12 0.92 -7.37 0.14 0.88 -0.12 0.10 0.96
β6 0.5 1.04 0.44 0.95 1.00 0.44 0.95 0.97 0.44 0.95 0.93 0.44 0.95 1.05 0.44 0.95
C-Index 0.69 -0.03 -0.05 -0.11 -0.16
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Table 3.2: Simulation Results for Continuous Covariates with Random Sampling Chart Review
5% Error Rate 10% Error Rate 20% Error Rate 30% Error Rate No Error
Truth % Bias MSE0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP
β1 0.3 1.55 0.41 0.95 1.80 0.41 0.95 2.23 0.41 0.96 2.69 0.41 0.96 1.32 0.41 0.95
β2 0.5 -0.98 1.98 0.94 -0.74 1.97 0.94 -0.33 1.97 0.94 0.10 1.96 0.94 -1.22 1.99 0.94
β3 0.3 -2.63 0.43 0.95 -3.80 0.43 0.95 -6.00 0.44 0.95 -8.27 0.45 0.95 -1.39 0.43 0.95
β4 0.5 -0.18 1.82 0.95 -0.24 1.82 0.95 -0.40 1.82 0.95 -0.57 1.83 0.95 -0.11 1.83 0.95
β5 0.3 1.05 0.38 0.96 1.05 0.38 0.96 1.01 0.38 0.96 0.98 0.39 0.96 1.05 0.38 0.96
β6 0.5 1.68 1.80 0.93 1.67 1.80 0.94 1.66 1.80 0.94 1.64 1.79 0.94 1.68 1.80 0.94
5% Event Rate C-Index 0.7 -0.03 -0.04 -0.08 -0.13
β1 0.3 1.35 0.41 0.96 1.31 0.41 0.95 1.30 0.41 0.96 1.28 0.41 0.95 1.32 0.41 0.95
β2 0.5 -1.22 1.99 0.94 -1.26 1.98 0.94 -1.25 1.99 0.93 -1.30 1.99 0.94 -1.22 1.99 0.94
β3 0.3 -1.40 0.43 0.95 -1.42 0.43 0.96 -1.41 0.43 0.95 -1.41 0.43 0.95 -1.39 0.43 0.95
β4 0.5 -0.13 1.83 0.95 -0.13 1.82 0.95 -0.16 1.83 0.95 -0.14 1.83 0.95 -0.11 1.83 0.95
β5 0.3 0.08 0.38 0.96 -1.17 0.37 0.97 -3.49 0.38 0.96 -5.78 0.40 0.95 1.05 0.38 0.96
β6 0.5 1.69 1.80 0.93 1.66 1.80 0.93 1.70 1.80 0.93 1.68 1.80 0.94 1.68 1.80 0.94
C-Index 0.7 -0.02 -0.04 -0.09 -0.14
β1 0.3 1.29 0.12 0.95 1.53 0.12 0.95 1.96 0.12 0.95 2.34 0.12 0.95 1.06 0.12 0.95
β2 0.5 0.75 0.46 0.94 0.99 0.46 0.94 1.40 0.46 0.94 1.80 0.46 0.94 0.53 0.46 0.94
β3 0.3 -2.63 0.12 0.94 -3.90 0.12 0.94 -6.35 0.15 0.91 -8.58 0.17 0.86 -1.38 0.11 0.95
β4 0.5 -0.10 0.45 0.95 -0.19 0.45 0.95 -0.42 0.45 0.94 -0.60 0.45 0.95 -0.01 0.45 0.95
β5 0.3 -0.14 0.10 0.95 -0.16 0.10 0.95 -0.23 0.10 0.95 -0.28 0.10 0.95 -0.12 0.10 0.96
β6 0.5 1.03 0.44 0.95 0.99 0.44 0.95 0.94 0.44 0.95 0.89 0.43 0.95 1.05 0.44 0.95
20% Event Rate C-Index 0.69 -0.03 -0.05 -0.10 -0.15
β1 0.3 1.05 0.12 0.95 1.02 0.12 0.95 0.97 0.12 0.95 0.91 0.12 0.95 1.06 0.12 0.95
β2 0.5 0.50 0.46 0.94 0.45 0.46 0.94 0.45 0.46 0.94 0.37 0.45 0.94 0.53 0.46 0.94
β3 0.3 -1.41 0.11 0.95 -1.43 0.11 0.95 -1.45 0.11 0.95 -1.47 0.11 0.95 -1.38 0.11 0.95
β4 0.5 -0.04 0.45 0.95 -0.07 0.45 0.94 -0.11 0.44 0.95 -0.09 0.45 0.95 -0.01 0.45 0.95
β5 0.3 -1.23 0.10 0.95 -2.40 0.10 0.95 -4.62 0.11 0.93 -6.73 0.14 0.89 -0.12 0.10 0.96
β6 0.5 1.05 0.44 0.95 1.01 0.44 0.94 0.98 0.44 0.95 0.93 0.44 0.95 1.05 0.44 0.95
C-Index 0.69 -0.02 -0.05 -0.10 -0.15
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Table 3.3: Simulation Results for Continuous Covariates with Case-Cohort Sampling Chart Review
5% Error Rate 10% Error Rate 20% Error Rate 30% Error Rate No Error
Truth % Bias MSE0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP
β1 0.3 1.54 0.41 0.95 1.76 0.41 0.95 2.21 0.41 0.96 2.62 0.41 0.96 1.32 0.41 0.95
β2 0.5 -0.99 1.99 0.93 -0.77 1.98 0.93 -0.34 1.98 0.94 0.06 1.98 0.94 -1.22 1.99 0.94
β3 0.3 -2.54 0.42 0.95 -3.59 0.42 0.94 -5.81 0.42 0.95 -7.84 0.43 0.95 -1.39 0.43 0.95
β4 0.5 -0.18 1.83 0.95 -0.23 1.83 0.95 -0.41 1.83 0.95 -0.53 1.83 0.95 -0.11 1.83 0.95
β5 0.3 1.04 0.38 0.96 1.05 0.38 0.96 1.01 0.38 0.96 0.99 0.39 0.96 1.05 0.38 0.96
β6 0.5 1.69 1.79 0.94 1.68 1.80 0.94 1.66 1.80 0.94 1.64 1.80 0.94 1.68 1.80 0.94
5% Event Rate C-Index 0.7 -0.01 -0.02 -0.05 -0.07
β1 0.3 1.33 0.41 0.96 1.30 0.41 0.95 1.31 0.41 0.95 1.30 0.41 0.95 1.32 0.41 0.95
β2 0.5 -1.23 1.99 0.93 -1.27 1.99 0.94 -1.24 1.99 0.93 -1.28 1.99 0.94 -1.22 1.99 0.94
β3 0.3 -1.40 0.43 0.95 -1.40 0.43 0.95 -1.39 0.43 0.95 -1.37 0.43 0.95 -1.39 0.43 0.95
β4 0.5 -0.13 1.83 0.95 -0.12 1.82 0.95 -0.14 1.83 0.95 -0.09 1.83 0.95 -0.11 1.83 0.95
β5 0.3 -0.10 0.38 0.97 -1.15 0.37 0.97 -3.13 0.36 0.96 -5.09 0.36 0.97 1.05 0.38 0.96
β6 0.5 1.70 1.80 0.93 1.69 1.80 0.93 1.70 1.80 0.93 1.72 1.80 0.94 1.68 1.80 0.94
C-Index 0.7 -0.01 -0.02 -0.05 -0.07
β1 0.3 1.29 0.12 0.95 1.53 0.12 0.95 1.95 0.12 0.95 2.32 0.12 0.95 1.06 0.12 0.95
β2 0.5 0.74 0.46 0.94 0.98 0.46 0.94 1.39 0.46 0.94 1.78 0.46 0.94 0.53 0.46 0.94
β3 0.3 -2.57 0.12 0.95 -3.77 0.12 0.94 -6.10 0.14 0.92 -8.18 0.17 0.87 -1.38 0.11 0.95
β4 0.5 -0.10 0.45 0.95 -0.19 0.45 0.95 -0.38 0.45 0.95 -0.54 0.45 0.95 -0.01 0.45 0.95
β5 0.3 -0.13 0.10 0.95 -0.15 0.10 0.95 -0.21 0.10 0.95 -0.23 0.10 0.95 -0.12 0.10 0.96
β6 0.5 1.03 0.44 0.95 1.01 0.44 0.95 0.96 0.44 0.95 0.93 0.44 0.95 1.05 0.44 0.95
20% Event Rate C-Index 0.69 -0.02 -0.04 -0.08 -0.12
β1 0.3 1.05 0.12 0.95 1.04 0.12 0.95 0.98 0.12 0.95 0.95 0.12 0.95 1.06 0.12 0.95
β2 0.5 0.51 0.46 0.94 0.45 0.46 0.94 0.47 0.46 0.94 0.40 0.45 0.94 0.53 0.46 0.94
β3 0.3 -1.41 0.11 0.95 -1.41 0.11 0.95 -1.43 0.11 0.95 -1.44 0.11 0.95 -1.38 0.11 0.95
β4 0.5 -0.02 0.45 0.95 -0.05 0.45 0.94 -0.10 0.45 0.95 -0.05 0.45 0.95 -0.01 0.45 0.95
β5 0.3 -1.19 0.10 0.96 -2.28 0.10 0.95 -4.43 0.11 0.93 -6.37 0.13 0.90 -0.12 0.10 0.96
β6 0.5 1.04 0.44 0.95 1.02 0.44 0.95 1.00 0.44 0.95 0.96 0.44 0.95 1.05 0.44 0.95
C-Index 0.69 -0.02 -0.04 -0.08 -0.12
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Table 3.4: Simulation Results for Binary Covariates
5% Error Rate 10% Error Rate 20% Error Rate 30% Error Rate No Error
Truth % Bias MSE0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP
β1 0.3 2.34 0.42 0.96 3.29 0.43 0.95 4.95 0.44 0.95 6.52 0.46 0.94 1.32 0.41 0.95
β2 0.5 -0.28 1.99 0.94 0.70 1.99 0.94 2.29 2.00 0.94 3.82 2.04 0.94 -1.22 1.99 0.94
β3 0.3 -1.75 0.43 0.95 -2.21 0.43 0.95 -2.85 0.43 0.95 -3.31 0.44 0.94 -1.39 0.43 0.95
β4 0.5 -3.50 2.00 0.94 -7.06 1.91 0.93 -11.54 2.24 0.92 -17.04 2.85 0.90 -0.11 1.83 0.95
β5 0.3 1.11 0.39 0.96 0.99 0.39 0.96 1.00 0.38 0.96 0.92 0.39 0.96 1.05 0.38 0.96
β6 0.5 1.72 1.80 0.94 1.62 1.80 0.94 1.59 1.81 0.94 1.53 1.82 0.93 1.68 1.80 0.94
5% Event Rate C-Index 0.7 -0.09 -0.21 -0.36 -0.54
β1 0.3 1.30 0.41 0.96 1.27 0.41 0.96 1.20 0.41 0.95 1.19 0.41 0.96 1.32 0.41 0.95
β2 0.5 -1.19 1.99 0.93 -1.29 1.99 0.94 -1.35 2.00 0.93 -1.35 2.00 0.93 -1.22 1.99 0.94
β3 0.3 -1.41 0.43 0.95 -1.47 0.43 0.95 -1.55 0.43 0.95 -1.53 0.43 0.95 -1.39 0.43 0.95
β4 0.5 -0.14 1.83 0.95 -0.22 1.83 0.95 -0.12 1.82 0.95 -0.23 1.83 0.95 -0.11 1.83 0.95
β5 0.3 1.01 0.38 0.96 0.95 0.38 0.97 0.90 0.39 0.96 0.90 0.38 0.96 1.05 0.38 0.96
β6 0.5 -1.29 1.85 0.93 -3.56 1.87 0.95 -8.47 2.10 0.94 -15.54 2.90 0.90 1.68 1.80 0.94
C-Index 0.7 -0.11 -0.21 -0.38 -0.63
β1 0.3 1.94 0.12 0.95 2.76 0.12 0.94 4.29 0.13 0.92 5.73 0.15 0.91 1.06 0.12 0.95
β2 0.5 1.33 0.46 0.94 2.14 0.47 0.93 3.66 0.48 0.93 5.05 0.52 0.92 0.53 0.46 0.94
β3 0.3 -1.78 0.11 0.95 -2.25 0.11 0.95 -2.98 0.12 0.94 -3.64 0.12 0.94 -1.38 0.11 0.95
β4 0.5 -2.87 0.49 0.94 -5.87 0.54 0.93 -10.90 0.77 0.88 -15.66 1.11 0.81 -0.01 0.45 0.95
β5 0.3 -0.11 0.10 0.96 -0.30 0.10 0.96 -0.41 0.10 0.96 -0.62 0.10 0.96 -0.12 0.10 0.96
β6 0.5 1.01 0.43 0.95 0.84 0.44 0.95 0.66 0.44 0.94 0.47 0.44 0.94 1.05 0.44 0.95
20% Event Rate C-Index 0.69 -0.11 -0.21 -0.40 -0.58
β1 0.3 0.99 0.12 0.95 0.91 0.12 0.95 0.73 0.11 0.95 0.62 0.12 0.94 1.06 0.12 0.95
β2 0.5 0.47 0.46 0.94 0.38 0.46 0.94 0.22 0.46 0.94 0.07 0.46 0.94 0.53 0.46 0.94
β3 0.3 -1.46 0.11 0.95 -1.56 0.11 0.95 -1.75 0.11 0.94 -1.89 0.11 0.95 -1.38 0.11 0.95
β4 0.5 -0.09 0.45 0.95 -0.26 0.45 0.94 -0.29 0.45 0.94 -0.56 0.45 0.94 -0.01 0.45 0.95
β5 0.3 -0.21 0.10 0.96 -0.31 0.10 0.96 -0.46 0.10 0.95 -0.62 0.10 0.96 -0.12 0.10 0.96
β6 0.5 -1.24 0.44 0.95 -3.69 0.49 0.94 -7.70 0.66 0.90 -12.70 0.93 0.86 1.05 0.44 0.95
C-Index 0.69 -0.11 -0.21 -0.39 -0.60
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Table 3.5: Simulation Results for Binary Covariates with Random Sampling Chart Review
5% Error Rate 10% Error Rate 20% Error Rate 30% Error Rate No Error
Truth % Bias MSE0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP
β1 0.3 2.24 0.42 0.96 3.11 0.42 0.95 4.61 0.44 0.95 6.07 0.45 0.94 1.32 0.41 0.95
β2 0.5 -0.38 1.99 0.94 0.51 1.99 0.94 1.97 1.99 0.94 3.42 2.03 0.94 -1.22 1.99 0.94
β3 0.3 -1.72 0.43 0.95 -2.13 0.43 0.95 -2.73 0.43 0.95 -3.14 0.44 0.94 -1.39 0.43 0.95
β4 0.5 -3.13 1.97 0.94 -6.52 1.89 0.93 -10.79 2.17 0.93 -15.64 2.65 0.91 -0.11 1.83 0.95
β5 0.3 1.11 0.39 0.96 1.00 0.39 0.96 0.99 0.38 0.96 0.92 0.39 0.96 1.05 0.38 0.96
β6 0.5 1.72 1.80 0.94 1.60 1.79 0.94 1.60 1.80 0.94 1.55 1.81 0.94 1.68 1.80 0.94
5% Event Rate C-Index 0.7 -0.08 -0.20 -0.34 -0.50
β1 0.3 1.30 0.41 0.95 1.29 0.41 0.96 1.21 0.41 0.95 1.22 0.41 0.96 1.32 0.41 0.95
β2 0.5 -1.22 1.99 0.93 -1.28 1.99 0.94 -1.36 1.99 0.94 -1.37 2.00 0.93 -1.22 1.99 0.94
β3 0.3 -1.41 0.43 0.95 -1.45 0.43 0.95 -1.56 0.43 0.95 -1.52 0.43 0.95 -1.39 0.43 0.95
β4 0.5 -0.13 1.83 0.95 -0.20 1.83 0.95 -0.11 1.81 0.95 -0.24 1.83 0.95 -0.11 1.83 0.95
β5 0.3 1.02 0.38 0.96 0.96 0.38 0.96 0.90 0.39 0.96 0.91 0.39 0.96 1.05 0.38 0.96
β6 0.5 -0.99 1.83 0.94 -3.14 1.85 0.95 -7.93 2.09 0.93 -13.70 2.69 0.91 1.68 1.80 0.94
C-Index 0.7 -0.10 -0.19 -0.35 -0.58
β1 0.3 1.86 0.12 0.95 2.61 0.12 0.94 4.00 0.13 0.93 5.30 0.14 0.92 1.06 0.12 0.95
β2 0.5 1.25 0.46 0.94 1.99 0.47 0.93 3.37 0.48 0.93 4.64 0.51 0.93 0.53 0.46 0.94
β3 0.3 -1.75 0.11 0.95 -2.17 0.11 0.95 -2.85 0.12 0.95 -3.44 0.12 0.94 -1.38 0.11 0.95
β4 0.5 -2.63 0.49 0.94 -5.43 0.54 0.93 -9.92 0.72 0.88 -14.38 1.02 0.83 -0.01 0.45 0.95
β5 0.3 -0.11 0.10 0.96 -0.29 0.10 0.96 -0.40 0.10 0.95 -0.58 0.10 0.96 -0.12 0.10 0.96
β6 0.5 1.00 0.44 0.95 0.85 0.44 0.95 0.69 0.44 0.95 0.53 0.44 0.94 1.05 0.44 0.95
20% Event Rate C-Index 0.69 -0.10 -0.19 -0.36 -0.53
β1 0.3 0.99 0.12 0.95 0.93 0.12 0.95 0.77 0.11 0.95 0.68 0.12 0.94 1.06 0.12 0.95
β2 0.5 0.46 0.46 0.94 0.38 0.46 0.94 0.24 0.46 0.94 0.10 0.45 0.94 0.53 0.46 0.94
β3 0.3 -1.46 0.11 0.95 -1.54 0.11 0.95 -1.72 0.11 0.94 -1.84 0.11 0.95 -1.38 0.11 0.95
β4 0.5 -0.08 0.45 0.94 -0.24 0.45 0.94 -0.26 0.45 0.94 -0.51 0.45 0.94 -0.01 0.45 0.95
β5 0.3 -0.19 0.10 0.96 -0.29 0.10 0.96 -0.43 0.10 0.96 -0.57 0.10 0.96 -0.12 0.10 0.96
β6 0.5 -1.06 0.44 0.95 -3.31 0.47 0.95 -6.85 0.61 0.92 -11.34 0.82 0.87 1.05 0.44 0.95
C-Index 0.69 -0.10 -0.19 -0.36 -0.54
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Table 3.6: Simulation Results for Binary Covariates with Case-Cohort Sampling Chart Review
5% Error Rate 10% Error Rate 20% Error Rate 30% Error Rate No Error
Truth % Bias MSE0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP % Bias
MSE
0.01 CP
β1 0.3 -0.02 0.41 0.95 -1.36 0.41 0.95 -3.92 0.42 0.95 -6.47 0.45 0.94 1.32 0.41 0.95
β2 0.5 -2.54 2.00 0.94 -3.85 2.03 0.93 -6.25 2.08 0.93 -8.63 2.17 0.93 -1.22 1.99 0.94
β3 0.3 -0.94 0.43 0.95 -0.66 0.43 0.95 -0.05 0.42 0.95 0.55 0.43 0.95 -1.39 0.43 0.95
β4 0.5 13.14 2.27 0.92 26.27 3.54 0.83 54.58 9.23 0.45 84.49 19.64 0.12 -0.11 1.83 0.95
β5 0.3 1.11 0.39 0.96 0.91 0.39 0.97 0.78 0.39 0.96 0.41 0.39 0.96 1.05 0.38 0.96
β6 0.5 1.72 1.80 0.93 1.55 1.79 0.95 1.37 1.80 0.94 0.98 1.81 0.94 1.68 1.80 0.94
5% Event Rate C-Index 0.7 0.35 0.75 1.68 2.77
β1 0.3 1.31 0.41 0.95 1.29 0.41 0.95 1.07 0.41 0.95 0.99 0.41 0.95 1.32 0.41 0.95
β2 0.5 -1.23 2.00 0.93 -1.36 1.99 0.93 -1.59 2.00 0.93 -1.87 2.01 0.94 -1.22 1.99 0.94
β3 0.3 -1.43 0.43 0.95 -1.47 0.43 0.95 -1.70 0.43 0.95 -1.92 0.43 0.95 -1.39 0.43 0.95
β4 0.5 -0.16 1.83 0.95 -0.30 1.83 0.95 -0.34 1.82 0.95 -0.67 1.84 0.95 -0.11 1.83 0.95
β5 0.3 1.01 0.38 0.97 0.96 0.38 0.96 0.87 0.39 0.96 0.67 0.39 0.96 1.05 0.38 0.96
β6 0.5 13.78 2.26 0.92 26.42 3.54 0.82 52.79 8.77 0.46 80.95 18.19 0.14 1.68 1.80 0.94
C-Index 0.7 0.35 0.74 1.63 2.68
β1 0.3 1.00 0.12 0.95 0.89 0.12 0.95 0.68 0.12 0.95 0.46 0.12 0.94 1.06 0.12 0.95
β2 0.5 0.43 0.46 0.94 0.35 0.46 0.94 0.21 0.45 0.94 -0.02 0.46 0.93 0.53 0.46 0.94
β3 0.3 -1.46 0.11 0.94 -1.59 0.11 0.95 -1.78 0.11 0.95 -2.05 0.11 0.94 -1.38 0.11 0.95
β4 0.5 3.52 0.50 0.93 7.16 0.60 0.91 15.54 1.07 0.76 25.09 2.04 0.55 -0.01 0.45 0.95
β5 0.3 -0.12 0.10 0.96 -0.28 0.10 0.96 -0.42 0.10 0.96 -0.77 0.10 0.96 -0.12 0.10 0.96
β6 0.5 1.00 0.43 0.95 0.87 0.44 0.95 0.63 0.44 0.94 0.34 0.44 0.95 1.05 0.44 0.95
20% Event Rate C-Index 0.69 0.09 0.18 0.38 0.61
β1 0.3 0.99 0.12 0.95 0.89 0.12 0.95 0.72 0.11 0.95 0.51 0.12 0.95 1.06 0.12 0.95
β2 0.5 0.46 0.46 0.94 0.37 0.46 0.94 0.15 0.46 0.94 -0.10 0.46 0.94 0.53 0.46 0.94
β3 0.3 -1.43 0.11 0.94 -1.52 0.11 0.95 -1.73 0.11 0.94 -1.93 0.11 0.95 -1.38 0.11 0.95
β4 0.5 -0.08 0.45 0.94 -0.22 0.45 0.94 -0.29 0.45 0.95 -0.65 0.45 0.94 -0.01 0.45 0.95
β5 0.3 -0.19 0.10 0.96 -0.29 0.10 0.95 -0.38 0.10 0.95 -0.63 0.10 0.96 -0.12 0.10 0.96
β6 0.5 4.58 0.49 0.93 8.43 0.62 0.90 17.23 1.22 0.73 26.27 2.19 0.51 1.05 0.44 0.95
C-Index 0.69 0.08 0.18 0.40 0.60
Chapter 4
Application to Evaluating the SOFA Score Using EHR Data
4.1 SMART Dataset
Data has been obtained from the Isotonic Solutions and Major Adverse Renal Events Trial
(SMART), which consists of 15,802 adult patients from five intensive care units at Vanderbilt Uni-
versity Medical Center. This was a pragmatic, unblinded, cluster-randomized, multiple-crossover
trial comparing clinical outcomes after the use of balanced crystalloids or saline for intravenous
fluid administration in critically ill adults (Semler et al., 2018). For this paper, a random sample of
300 observations was used, which includes demographic information as well as the eSOFA score
and mSOFA score for the six components of the SOFA score. There were 39 cases in this sample
for an event rate of 39/300 = 13%. Descripive statistics for this dataset can be found in Table 4.1.
The cases were older, and there were a higher proportion of males in the cases than the non-cases.
Also, the overall SOFA scores, both eSOFA and mSOfA, were higher for the cases. The neurologic
component had the largest difference between the cases and non-cases.
4.2 Comparison of eSOFA Score and mSOFA Score
An eSOFA score has been developed that can extract data from EHR using natural language
processing. This score has been calculated for all patients in the SMART trial. A benefit of using
the eSOFA score is that it can be calculated much faster than the mSOFA score. However, there
will be errors present when the eSOFA score doesn’t match the mSOFA score. The mSOFA score
has been calculated for a random sample of 300 patients from the SMART trial.
The bias between the mSOFA score and the eSOFA score was found by subtracting the mSOFA
scores from the eSOFA scores for each patient in the sample. The bias was calculated for each
component of the SOFA score. The results can be found in Figure 4.1. Note that this figure was
produced with jitter to more easily see how many patients were at each point. The respiratory
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Table 4.1: Descriptive Statistics for SMART Data
Non-Cases Cases Combined
N = 261 N = 39 N = 300
Age 44.81 58.71 71.12 52.52 64.71 69.44 45.00 59.14 71.12
Race
Asian 0.01 ( 2) 0.00 ( 0) 0.01 ( 2)
Black 0.10 ( 25) 0.10 ( 4) 0.10 ( 29)
Unknown 0.07 ( 17) 0.18 ( 7) 0.08 ( 24)
White 0.83 (217) 0.72 ( 28) 0.82 (245)
Gender
Male 0.56 (145) 0.67 ( 26) 0.57 (171)
Unit
CVICU 0.18 ( 46) 0.23 ( 9) 0.18 ( 55)
MICU 0.34 ( 90) 0.46 ( 18) 0.36 (108)
NEICU 0.18 ( 48) 0.21 ( 8) 0.19 ( 56)
SICU 0.09 ( 24) 0.03 ( 1) 0.08 ( 25)
TICU 0.20 ( 53) 0.08 ( 3) 0.19 ( 56)
Source of Admission
Emergency department 0.54 (140) 0.46 ( 18) 0.53 (158)
Hospital ward 0.07 ( 18) 0.15 ( 6) 0.08 ( 24)
Operating room 0.19 ( 50) 0.00 ( 0) 0.17 ( 50)
Other 0.07 ( 17) 0.03 ( 1) 0.06 ( 18)
Transfer from another hospital 0.14 ( 36) 0.36 ( 14) 0.17 ( 50)
eSOFA 3 4 7 6 8 12 3 5 8
mSOFA 2 4 7 5.5 8 12 2 5 8
eSOFA (Cardiovascular) 0 1 1 0 1 3 0 1 1
mSOFA (Cardiovascular) 0 1 1 0 1 3 0 1 1
eSOFA (Respiratory) 1 1 2 1 2 3 1 2 2
mSOFA (Respiratory) 1 2 2 1 2 3 1 2 2
eSOFA (Renal) 0 0 3 0 1 3 0 0 3
mSOFA (Renal) 0 0 1 0 1 3 0 0 1
eSOFA (Hepatic) 0 0 0 0 0 1.5 0 0 0
mSOFA (Hepatic) 0 0 0 0 0 1.5 0 0 0
eSOFA (Neurologic) 0 1 2 0.5 4 4 0 1 3
mSOFA (Neurologic) 0 1 2 0.5 3 4 0 1 3
eSOFA (Hematological) 0 0 0 0 0 1 0 0 0
mSOFA (Hematological) 0 0 0 0 0 1 0 0 0
a b c represent the lower quartile a, the median b, and the upper quartile c for continuous variables.
Numbers after proportions are frequencies.
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and renal components have the most bias, while the hepatic and neurologic components have the
least. Table 4.2 shows a summary of the distributions of the bias for each of the components.
The respiratory component had the most patients (n=79, 26%) with disagreement between the
mSOFA and eSOFA scores, while the hepatic and neurologic components had the least (n=1,
0.33%). For the cardiovascular, respiratory, and renal components, there was bias in both the
positive and negative directions, whereas the four instances of bias in the hepatic, neurologic, and
hematological components were all in the positive direction, meaning that the eSOFA score was
lower than the mSOFA score.
Figure 4.1: Bias Between mSOFA and eSOFA Scores
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Table 4.2: Summary of Errors for SOFA Score Components
# with error (%) Mean S.D. Min. Max.
Cardiovascular 12 (4%) -0.02 0.32 -4 1
Respiratory 79 (26%) 0.01 0.68 -2 3
Renal 63 (21%) 0.33 1.17 -4 4
Hepatic 1 (0.33%) 0.00 0.06 0 1
Neurologic 1 (0.33%) 0.00 0.06 0 1
Hematological (0.67%) 2 0.01 0.13 0 2
4.3 Application of Chart Review Strategies
A Cox proportional hazards model was fit using the mSOFA components of the SOFA score to
obtain the gold standard coefficients. These can be found in the ”Truth” column of Table 4.3. The
model was also fit using the eSOFA score components without correcting any errors; the percent
bias for these estimates can be found in the ”No Correction” column of Table 4.3. Next, the chart
review sampling strategies were used to correct errors by replacing the eSOFA score with the
mSOFA score for the sampled patients. Two different sample sizes were examined for the random
sampling (N=100 and N=150). The case-cohort sampling strategy corrected errors for the 39 cases
and a random sample of 100-39 = 61 non-cases. The model was fit 100 times using each of these
strategies, and the percent bias for the effect estimate corresponding to each of the SOFA score
components as well as the percent bias for the C-index was obtained in each of the repetitions. The
average of these percent biases after correcting errors using each of the chart review strategies can
be found in Table 4.3.
Table 4.3: Cox PH Model Results
% Bias
No Correction Random Sampling Random Sampling Case-Cohort Sampling
Truth (N=100) (N=150) (N=100)
β1 (Cardiovascular) -0.09 -5.11 -8.91 -11.29 -58.79
β2 (Respiratory) 0.16 -30.49 -19.21 -12.30 -1.33
β3 (Renal) 0.21 -77.17 -54.92 -47.35 -73.19
β4 (Hepatic) 0.68 4.88 2.93 2.28 1.07
β5 (Neurologic) 0.53 6.58 3.35 2.18 -2.08
β6 (Hematological) -0.36 -11.23 -10.40 -8.98 -10.01
C-Index 0.79 -0.40 -0.34 -0.25 -0.90
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The random sampling with 150 patients seemed to perform the best out of the three chart
review strategies examined in terms of percent bias. This method resulted in a lower magnitude
percent bias compared to the model fit using the eSOFA score without correcting errors for the
coefficients β2 through β6. However, for β1, the percent bias after performing chart reviews on a
random sample of 150 patients was -11.29 compared to a percent bias of -5.11 when fitting the
model without correcting errors and a percent bias of -8.91 when fitting the model after correcting
errors for a random sample of 100 patients. Similarly, the percent bias for the estimates from the
model after correcting for errors using chart reviews with case-cohort sampling compared to no
correction had a smaller magnitude for all of the coefficients β2 through β6, but a larger magnitude
for β1 (-58.79 vs. -5.11). The C-index from fitting the model with the mSOFA components was
0.79, and there was less than 1% bias in all scenarios.
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Chapter 5
Discussion
This paper evaluated the impact of data quality on risk factor assessment and risk prediction
performance and investigated different chart review strategies in reducing bias in the context of
a Cox proportional hazards model. Unlike traditional utilities of chart review where only chart
reviewed data are used in the analysis, this work aims to maximize data resources using both chart
reviewed and non-chart reviewed records.
The simulation studies presented in this paper revealed that data quality problems result in bias
of risk factor effects under a Cox proportional hazards model framework as expected. Specifi-
cally, a greater proportion of errors results in more bias of the effects regardless of the event rate
or whether the covariate of interest is continuous or binary, correlated or uncorrelated with other
covariates. For continuous covariates, performing chart review reduces the bias of the effect esti-
mates, with case-cohort sampling performing slightly better than random sampling. For the binary
variables, the random sampling strategy resulted in improved estimates in terms of percent bias.
The case-cohort sampling strategy for the binary covariates resulted in larger bias due to the over-
representative cases where the value of 0 (representing absence of a risk factor) was corrected to 1
(representing presence of a risk factor). As expected, the simulation studies also revealed that the
proportion of bias reduction after performing chart reviews may be linked to the proportion of ob-
servations being reviewed. For example, in the simulation studies where 10% of the observations
were reviewed, the bias improved by about 5% to 15% after correcting errors using chart reviews.
For the application using the SOFA score, we were only able to obtain a random sample of
300 patients from the 15,802 patients enrolled in the SMART study. Performing chart review
on a random sample of 150 patients resulted in the smallest percent bias of the effect estimates.
Applying these methods to the entire dataset is a potential future analysis that would be more
representative of how these chart review sampling strategies would behave in real EHR data.
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This paper is our first attempt in the broad area of EHR data quality problems in a risk predic-
tion model framework. With better understanding of the bias in model estimation and performance
due to data errors and potential utilities of chart review in bias reduction, we identified opportuni-
ties to develop statistical methods to address data quality problems through chart review. Future
statistical methods development will focus on areas such as accounting for chart review sampling
probability, combining data error modeling with non-chart reviewed records to further reduce bias,
and identifying optimal sampling strategies for chart review.
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